Population-scale testing can suppress the spread of COVID-19

We propose an additional intervention that would contribute to the control of the COVID-19 pandemic, offer more protection for people working in essential jobs, and help guide an eventual reopening of society. The intervention is based on: (1) testing every individual (2) repeatedly, and (3) self-quarantine of infected individuals. Using a standard epidemiological model (SIR), we show here that by identification and isolation of the majority of infectious individuals, including those who may be asymptomatic, the reproduction number R0 of SARS-CoV-2 would be reduced well below 1.0, and the epidemic would collapse. We replicate these observations in a more complex stochastic dynamic model on a social network graph. We also find that the testing regime would be additive to other interventions, and be effective at any level of prevalence. If adopted as a policy, any industrial society could sustain the regime for as long as it takes to find a safe and effective cure or vaccine. Our model also indicates that unlike sampling-based tests, population-scale testing does not need to be very accurate: false negative rates up to 15% could be tolerated if 80% comply with testing every ten days, and false positives can be almost arbitrarily high when a high fraction of the population is already effectively quarantined. Testing at the required scale would be feasible if existing qPCR-based methods are scaled up and multiplexed. A mass produced, low throughput field test kit could also be carried out at home. Economic analysis also supports the feasibility of the approach: current reagent costs for tests are in the range of a dollar or less, and the estimated benefits for population-scale testing are so large that the policy would be cost-effective even if the costs were larger by more than two orders of magnitude. To identify both active and previous infections, both viral RNA and antibodies could be tested. All technologies to build such test kits, and to produce them in the scale required to test the entire world's population exist already. Integrating them, scaling up production, and implementing the testing regime will require resources and planning, but at a scale that is very small compared to the effort that every nation would devote to defending itself against a more traditional foe.

[1]  C. Whittaker,et al.  Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .

[2]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[3]  I. Sakharov,et al.  Isothermal Nucleic Acid Amplification Techniques and Their Use in Bioanalysis , 2020, Biochemistry (Moscow).

[4]  Ruiyun Li,et al.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (COVID-19) , 2020, medRxiv.

[5]  M. Lipsitch,et al.  How generation intervals shape the relationship between growth rates and reproductive numbers , 2007, Proceedings of the Royal Society B: Biological Sciences.

[6]  Molly M Stevens,et al.  Platinum Nanocatalyst Amplification: Redefining the Gold Standard for Lateral Flow Immunoassays with Ultrabroad Dynamic Range , 2017, ACS nano.

[7]  An Pan,et al.  Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China , 2020, medRxiv.

[8]  Xin Li,et al.  Rapid colorimetric detection of COVID-19 coronavirus using a reverse tran-scriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic plat-form: iLACO , 2020, medRxiv.

[9]  P. Jha,et al.  Pandemics: Risks, Impacts, and Mitigation -- Disease Control Priorities: Improving Health and Reducing Poverty , 2017 .

[10]  Tobias Bleicker,et al.  Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster , 2020, medRxiv.

[11]  Julian Peto,et al.  Covid-19 mass testing facilities could end the epidemic rapidly , 2020, BMJ.

[12]  N. Tanner,et al.  Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP , 2020, medRxiv.

[13]  L. Pena,et al.  Development and Validation of Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) for Rapid Detection of ZIKV in Mosquito Samples from Brazil , 2019, Scientific Reports.

[14]  V. Pelechano,et al.  Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform , 2020, Clinical chemistry.

[15]  S. Linnarsson,et al.  Counting absolute numbers of molecules using unique molecular identifiers , 2011, Nature Methods.

[16]  Natasha S Crowcroft,et al.  The basic reproduction number (R0) of measles: a systematic review. , 2017, The Lancet. Infectious diseases.

[17]  Sai Bi,et al.  Isothermal exponential amplification techniques: From basic principles to applications in electrochemical biosensors. , 2018, Biosensors & bioelectronics.

[18]  J. E. Muñoz-Medina,et al.  Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance , 2020, Nature Microbiology.

[19]  W. O. Kermack,et al.  Contributions to the mathematical theory of epidemics--I. 1927. , 1991, Bulletin of mathematical biology.

[20]  S. Eubank,et al.  Commentary on Ferguson, et al., “Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand” , 2020, Bulletin of Mathematical Biology.

[21]  E. Rubin,et al.  Pandemics: Risks, Impacts, and Mitigation , 2017 .

[22]  Ruiyun Li,et al.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) , 2020, Science.

[23]  Kyle F. Herkenhoff,et al.  An SEIR Infectious Disease Model with Testing and Conditional Quarantine , 2020 .

[24]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[25]  Kyle F. Herkenhoff,et al.  An Seir Infectious Disease Model with Testing and Conditional Quarantine , 2020, SSRN Electronic Journal.

[26]  Christian Drosten,et al.  Serological assays for emerging coronaviruses: Challenges and pitfalls , 2014, Virus Research.

[27]  A. Sterrett On the Detection of Defective Members of Large Populations , 1957 .

[28]  Alimuddin Zumla,et al.  Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread , 2014, The Lancet Infectious Diseases.

[29]  Yaniv Erlich A vision for ubiquitous sequencing , 2015, bioRxiv.

[30]  C. Fan,et al.  Isothermal Amplification of Nucleic Acids. , 2015, Chemical reviews.

[31]  M. Beer,et al.  Loeffler 4.0: Diagnostic Metagenomics , 2017, Advances in Virus Research.